Patent ID: 11919945
Assignee: THE ROCKEFELLER UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  G | IPC A  C  G

Claim 0:
1. An isolated anti-SARS-CoV-2 antibody or antigen-binding fragment thereof that binds specifically to a SARS-CoV-2 antigen, comprising HCDR1, HCDR2, HCDR3, LCDR1, LCDR2, and LCDR3 comprising respective amino acid sequences of (a) SEQ ID NOs: 4600, 4601, 4602, 4603, 4604, and 4605; (b) SEQ ID NOs: 4606, 4607, 4608, 4609, 4610, and 4611; (c) SEQ ID Nos: 4612, 4613, 4614, 4615, 4616, and 4617; (d) SEQ ID NOs: 4618, 4619, 4620, 4621, 4622, and 4623; (e) SEQ ID NOs: 4624, 4625, 4626, 4627, 4628, and 4629; (f) SEQ ID NOs: 4630, 4631, 4632, 4633, 4634, and 4635; (g) SEQ ID NOs: 4642, 4643, 4644, 4645, 4646, and 4647; (h) SEQ ID NOs: 4648, 4649, 4650, 4651, 4652, and 4653; (i) SEQ ID NOs: 4654, 4655, 4656, 4657, 4658, and 4659; or (j) SEQ ID NOs: 4660, 4661, 4662, 4663, 4664, and 4665.